Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027
Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027 Professional…
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…
Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration
Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration…
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership…
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC Professional…
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership Professional…
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…
Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051
Lucid Diligence Brief: ENA Respiratory Series B for intranasal INNA-051…
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies Professional…
Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A
Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A Professional…